منبع: Zacks Investment Research
خبرگزاری
سهام
اهمیت متوسط

BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised
BioMarin stock rises on Q2 sales beat and raises 2026 outlook, highlighting strong Voxzogo growth, Amicus additions and momentum in key therapies.
نمادهای مرتبط
1
B
BMRN
BMRN
منبع: Zacks Investment Research
مشاهده منبع